4//SEC Filing
Dinsmore Christopher 4
Accession 0001209191-21-055252
CIK 0001741830other
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 1:23 PM ET
Size
9.0 KB
Accession
0001209191-21-055252
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
Dinsmore Christopher
Chief Scientific Officer
Transactions
- Sale
Common Stock
2021-09-07$21.91/sh−9,189$201,302→ 96,360 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-09-07−9,189→ 324,497 totalExercise: $3.27Exp: 2030-06-14→ Common Stock (9,189 underlying) - Exercise/Conversion
Common Stock
2021-09-07$3.27/sh+9,189$30,048→ 105,549 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2021.
- [F2]The weighted average sale price for the transaction reported was $21.9068, and the range of prices were between $20.85 and $22.78. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]Immediately exercisable.
Documents
Issuer
Kronos Bio, Inc.
CIK 0001741830
Entity typeother
Related Parties
1- filerCIK 0001826766
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 1:23 PM ET
- Size
- 9.0 KB